nodes	percent_of_prediction	percent_of_DWPC	metapath
Cevimeline—Cholinergic Muscarinic Agonists—Pilocarpine—glaucoma	0.697	1	CiPCiCtD
Cevimeline—CHRM3—Carbachol—glaucoma	0.0397	0.185	CbGbCtD
Cevimeline—CHRM3—Pilocarpine—glaucoma	0.0369	0.172	CbGbCtD
Cevimeline—CHRM1—Carbachol—glaucoma	0.0345	0.161	CbGbCtD
Cevimeline—CHRM1—Pilocarpine—glaucoma	0.0321	0.149	CbGbCtD
Cevimeline—CYP2D6—Carteolol—glaucoma	0.0142	0.0662	CbGbCtD
Cevimeline—CYP2D6—Betaxolol—glaucoma	0.00962	0.0447	CbGbCtD
Cevimeline—CYP2D6—Methazolamide—glaucoma	0.00729	0.0339	CbGbCtD
Cevimeline—CYP3A4—Pilocarpine—glaucoma	0.00686	0.0319	CbGbCtD
Cevimeline—CYP2D6—Timolol—glaucoma	0.0062	0.0288	CbGbCtD
Cevimeline—CYP3A4—Brinzolamide—glaucoma	0.00538	0.0251	CbGbCtD
Cevimeline—CYP2D6—Clonidine—glaucoma	0.00527	0.0245	CbGbCtD
Cevimeline—CYP3A4—Dorzolamide—glaucoma	0.0052	0.0242	CbGbCtD
Cevimeline—CYP3A4—Methazolamide—glaucoma	0.00463	0.0216	CbGbCtD
Cevimeline—CYP3A4—Acetazolamide—glaucoma	0.00371	0.0172	CbGbCtD
Cevimeline—CYP3A4—Clonidine—glaucoma	0.00335	0.0156	CbGbCtD
Cevimeline—Hyperglycaemia—Timolol—glaucoma	3.17e-05	0.000362	CcSEcCtD
Cevimeline—Agitation—Clonidine—glaucoma	3.16e-05	0.000361	CcSEcCtD
Cevimeline—Paraesthesia—Pilocarpine—glaucoma	3.16e-05	0.000361	CcSEcCtD
Cevimeline—Asthenia—Bimatoprost—glaucoma	3.16e-05	0.000361	CcSEcCtD
Cevimeline—Fatigue—Brinzolamide—glaucoma	3.16e-05	0.00036	CcSEcCtD
Cevimeline—Dyspnoea—Pilocarpine—glaucoma	3.14e-05	0.000358	CcSEcCtD
Cevimeline—Pain—Brinzolamide—glaucoma	3.13e-05	0.000357	CcSEcCtD
Cevimeline—Somnolence—Pilocarpine—glaucoma	3.13e-05	0.000357	CcSEcCtD
Cevimeline—Depression—Timolol—glaucoma	3.12e-05	0.000357	CcSEcCtD
Cevimeline—Angiopathy—Betaxolol—glaucoma	3.12e-05	0.000357	CcSEcCtD
Cevimeline—Pruritus—Bimatoprost—glaucoma	3.11e-05	0.000356	CcSEcCtD
Cevimeline—Diarrhoea—Apraclonidine—glaucoma	3.11e-05	0.000355	CcSEcCtD
Cevimeline—Malaise—Clonidine—glaucoma	3.1e-05	0.000355	CcSEcCtD
Cevimeline—Dyspepsia—Pilocarpine—glaucoma	3.1e-05	0.000354	CcSEcCtD
Cevimeline—Chills—Betaxolol—glaucoma	3.09e-05	0.000353	CcSEcCtD
Cevimeline—Syncope—Clonidine—glaucoma	3.09e-05	0.000353	CcSEcCtD
Cevimeline—Arrhythmia—Betaxolol—glaucoma	3.08e-05	0.000351	CcSEcCtD
Cevimeline—Feeling abnormal—Dorzolamide—glaucoma	3.07e-05	0.00035	CcSEcCtD
Cevimeline—Decreased appetite—Pilocarpine—glaucoma	3.06e-05	0.000349	CcSEcCtD
Cevimeline—Feeling abnormal—Travoprost—glaucoma	3.05e-05	0.000349	CcSEcCtD
Cevimeline—Conjunctivitis—Timolol—glaucoma	3.05e-05	0.000348	CcSEcCtD
Cevimeline—Gastrointestinal pain—Dorzolamide—glaucoma	3.04e-05	0.000348	CcSEcCtD
Cevimeline—Alopecia—Betaxolol—glaucoma	3.04e-05	0.000347	CcSEcCtD
Cevimeline—Palpitations—Clonidine—glaucoma	3.04e-05	0.000347	CcSEcCtD
Cevimeline—Gastrointestinal pain—Travoprost—glaucoma	3.03e-05	0.000346	CcSEcCtD
Cevimeline—Loss of consciousness—Clonidine—glaucoma	3.03e-05	0.000346	CcSEcCtD
Cevimeline—Feeling abnormal—Brinzolamide—glaucoma	3.02e-05	0.000344	CcSEcCtD
Cevimeline—Pain—Pilocarpine—glaucoma	3.01e-05	0.000344	CcSEcCtD
Cevimeline—Constipation—Pilocarpine—glaucoma	3.01e-05	0.000344	CcSEcCtD
Cevimeline—Cough—Clonidine—glaucoma	3e-05	0.000343	CcSEcCtD
Cevimeline—Dizziness—Apraclonidine—glaucoma	3e-05	0.000343	CcSEcCtD
Cevimeline—Malnutrition—Betaxolol—glaucoma	3e-05	0.000342	CcSEcCtD
Cevimeline—Urticaria—Dorzolamide—glaucoma	2.96e-05	0.000338	CcSEcCtD
Cevimeline—Epistaxis—Timolol—glaucoma	2.95e-05	0.000337	CcSEcCtD
Cevimeline—Body temperature increased—Dorzolamide—glaucoma	2.94e-05	0.000336	CcSEcCtD
Cevimeline—Abdominal pain—Dorzolamide—glaucoma	2.94e-05	0.000336	CcSEcCtD
Cevimeline—Sinusitis—Timolol—glaucoma	2.94e-05	0.000336	CcSEcCtD
Cevimeline—Dysgeusia—Betaxolol—glaucoma	2.93e-05	0.000335	CcSEcCtD
Cevimeline—Chest pain—Clonidine—glaucoma	2.93e-05	0.000335	CcSEcCtD
Cevimeline—Arthralgia—Clonidine—glaucoma	2.93e-05	0.000335	CcSEcCtD
Cevimeline—Abdominal pain—Travoprost—glaucoma	2.93e-05	0.000335	CcSEcCtD
Cevimeline—Agranulocytosis—Timolol—glaucoma	2.92e-05	0.000334	CcSEcCtD
Cevimeline—Anxiety—Clonidine—glaucoma	2.92e-05	0.000334	CcSEcCtD
Cevimeline—Asthenia—Acetazolamide—glaucoma	2.91e-05	0.000333	CcSEcCtD
Cevimeline—Dizziness—Bimatoprost—glaucoma	2.91e-05	0.000332	CcSEcCtD
Cevimeline—Urticaria—Brinzolamide—glaucoma	2.91e-05	0.000332	CcSEcCtD
Cevimeline—Feeling abnormal—Pilocarpine—glaucoma	2.9e-05	0.000331	CcSEcCtD
Cevimeline—Discomfort—Clonidine—glaucoma	2.9e-05	0.000331	CcSEcCtD
Cevimeline—Vomiting—Apraclonidine—glaucoma	2.89e-05	0.00033	CcSEcCtD
Cevimeline—Muscle spasms—Betaxolol—glaucoma	2.88e-05	0.000329	CcSEcCtD
Cevimeline—Gastrointestinal pain—Pilocarpine—glaucoma	2.88e-05	0.000329	CcSEcCtD
Cevimeline—Hypersensitivity—Brimonidine—glaucoma	2.87e-05	0.000328	CcSEcCtD
Cevimeline—Dermatitis—Apraclonidine—glaucoma	2.86e-05	0.000327	CcSEcCtD
Cevimeline—Headache—Apraclonidine—glaucoma	2.84e-05	0.000325	CcSEcCtD
Cevimeline—Confusional state—Clonidine—glaucoma	2.83e-05	0.000323	CcSEcCtD
Cevimeline—Rhinitis—Timolol—glaucoma	2.82e-05	0.000322	CcSEcCtD
Cevimeline—Oedema—Clonidine—glaucoma	2.81e-05	0.000321	CcSEcCtD
Cevimeline—Tremor—Betaxolol—glaucoma	2.81e-05	0.000321	CcSEcCtD
Cevimeline—Hallucination—Timolol—glaucoma	2.8e-05	0.00032	CcSEcCtD
Cevimeline—Asthenia—Brimonidine—glaucoma	2.8e-05	0.000319	CcSEcCtD
Cevimeline—Infection—Clonidine—glaucoma	2.79e-05	0.000319	CcSEcCtD
Cevimeline—Abdominal pain—Pilocarpine—glaucoma	2.78e-05	0.000318	CcSEcCtD
Cevimeline—Body temperature increased—Pilocarpine—glaucoma	2.78e-05	0.000318	CcSEcCtD
Cevimeline—Ill-defined disorder—Betaxolol—glaucoma	2.78e-05	0.000318	CcSEcCtD
Cevimeline—Diarrhoea—Acetazolamide—glaucoma	2.78e-05	0.000317	CcSEcCtD
Cevimeline—Rash—Bimatoprost—glaucoma	2.78e-05	0.000317	CcSEcCtD
Cevimeline—Dermatitis—Bimatoprost—glaucoma	2.77e-05	0.000317	CcSEcCtD
Cevimeline—Oedema peripheral—Timolol—glaucoma	2.77e-05	0.000316	CcSEcCtD
Cevimeline—Anaemia—Betaxolol—glaucoma	2.77e-05	0.000316	CcSEcCtD
Cevimeline—Shock—Clonidine—glaucoma	2.76e-05	0.000316	CcSEcCtD
Cevimeline—Pruritus—Brimonidine—glaucoma	2.76e-05	0.000315	CcSEcCtD
Cevimeline—Headache—Bimatoprost—glaucoma	2.76e-05	0.000315	CcSEcCtD
Cevimeline—Nervous system disorder—Clonidine—glaucoma	2.75e-05	0.000315	CcSEcCtD
Cevimeline—Thrombocytopenia—Clonidine—glaucoma	2.75e-05	0.000314	CcSEcCtD
Cevimeline—Hypersensitivity—Dorzolamide—glaucoma	2.74e-05	0.000313	CcSEcCtD
Cevimeline—Tachycardia—Clonidine—glaucoma	2.74e-05	0.000313	CcSEcCtD
Cevimeline—Hypersensitivity—Travoprost—glaucoma	2.73e-05	0.000312	CcSEcCtD
Cevimeline—Skin disorder—Clonidine—glaucoma	2.73e-05	0.000312	CcSEcCtD
Cevimeline—Hyperhidrosis—Clonidine—glaucoma	2.72e-05	0.00031	CcSEcCtD
Cevimeline—Visual impairment—Timolol—glaucoma	2.71e-05	0.00031	CcSEcCtD
Cevimeline—Malaise—Betaxolol—glaucoma	2.7e-05	0.000309	CcSEcCtD
Cevimeline—Nausea—Apraclonidine—glaucoma	2.7e-05	0.000308	CcSEcCtD
Cevimeline—Hypersensitivity—Brinzolamide—glaucoma	2.7e-05	0.000308	CcSEcCtD
Cevimeline—Vertigo—Betaxolol—glaucoma	2.69e-05	0.000307	CcSEcCtD
Cevimeline—Syncope—Betaxolol—glaucoma	2.69e-05	0.000307	CcSEcCtD
Cevimeline—Dizziness—Acetazolamide—glaucoma	2.69e-05	0.000307	CcSEcCtD
Cevimeline—Anorexia—Clonidine—glaucoma	2.68e-05	0.000306	CcSEcCtD
Cevimeline—Asthenia—Dorzolamide—glaucoma	2.67e-05	0.000305	CcSEcCtD
Cevimeline—Asthenia—Travoprost—glaucoma	2.66e-05	0.000304	CcSEcCtD
Cevimeline—Palpitations—Betaxolol—glaucoma	2.65e-05	0.000302	CcSEcCtD
Cevimeline—Pruritus—Dorzolamide—glaucoma	2.63e-05	0.000301	CcSEcCtD
Cevimeline—Loss of consciousness—Betaxolol—glaucoma	2.63e-05	0.000301	CcSEcCtD
Cevimeline—Eye disorder—Timolol—glaucoma	2.63e-05	0.0003	CcSEcCtD
Cevimeline—Asthenia—Brinzolamide—glaucoma	2.63e-05	0.0003	CcSEcCtD
Cevimeline—Hypotension—Clonidine—glaucoma	2.63e-05	0.0003	CcSEcCtD
Cevimeline—Pruritus—Travoprost—glaucoma	2.62e-05	0.0003	CcSEcCtD
Cevimeline—Tinnitus—Timolol—glaucoma	2.62e-05	0.000299	CcSEcCtD
Cevimeline—Cough—Betaxolol—glaucoma	2.62e-05	0.000299	CcSEcCtD
Cevimeline—Nausea—Bimatoprost—glaucoma	2.61e-05	0.000299	CcSEcCtD
Cevimeline—Cardiac disorder—Timolol—glaucoma	2.61e-05	0.000298	CcSEcCtD
Cevimeline—Hypersensitivity—Pilocarpine—glaucoma	2.59e-05	0.000296	CcSEcCtD
Cevimeline—Pruritus—Brinzolamide—glaucoma	2.59e-05	0.000296	CcSEcCtD
Cevimeline—Vomiting—Acetazolamide—glaucoma	2.58e-05	0.000295	CcSEcCtD
Cevimeline—Dizziness—Brimonidine—glaucoma	2.58e-05	0.000294	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Clonidine—glaucoma	2.56e-05	0.000292	CcSEcCtD
Cevimeline—Angiopathy—Timolol—glaucoma	2.55e-05	0.000291	CcSEcCtD
Cevimeline—Myalgia—Betaxolol—glaucoma	2.55e-05	0.000291	CcSEcCtD
Cevimeline—Chest pain—Betaxolol—glaucoma	2.55e-05	0.000291	CcSEcCtD
Cevimeline—Arthralgia—Betaxolol—glaucoma	2.55e-05	0.000291	CcSEcCtD
Cevimeline—Diarrhoea—Dorzolamide—glaucoma	2.55e-05	0.000291	CcSEcCtD
Cevimeline—Headache—Acetazolamide—glaucoma	2.54e-05	0.000291	CcSEcCtD
Cevimeline—Anxiety—Betaxolol—glaucoma	2.54e-05	0.00029	CcSEcCtD
Cevimeline—Insomnia—Clonidine—glaucoma	2.54e-05	0.00029	CcSEcCtD
Cevimeline—Diarrhoea—Travoprost—glaucoma	2.54e-05	0.00029	CcSEcCtD
Cevimeline—Asthenia—Pilocarpine—glaucoma	2.52e-05	0.000288	CcSEcCtD
Cevimeline—Paraesthesia—Clonidine—glaucoma	2.52e-05	0.000288	CcSEcCtD
Cevimeline—Discomfort—Betaxolol—glaucoma	2.52e-05	0.000288	CcSEcCtD
Cevimeline—Arrhythmia—Timolol—glaucoma	2.51e-05	0.000287	CcSEcCtD
Cevimeline—Dyspnoea—Clonidine—glaucoma	2.5e-05	0.000286	CcSEcCtD
Cevimeline—Diarrhoea—Brinzolamide—glaucoma	2.5e-05	0.000286	CcSEcCtD
Cevimeline—Somnolence—Clonidine—glaucoma	2.5e-05	0.000285	CcSEcCtD
Cevimeline—Pruritus—Pilocarpine—glaucoma	2.49e-05	0.000284	CcSEcCtD
Cevimeline—Alopecia—Timolol—glaucoma	2.49e-05	0.000284	CcSEcCtD
Cevimeline—Confusional state—Betaxolol—glaucoma	2.47e-05	0.000282	CcSEcCtD
Cevimeline—Dizziness—Dorzolamide—glaucoma	2.46e-05	0.000281	CcSEcCtD
Cevimeline—Rash—Brimonidine—glaucoma	2.46e-05	0.000281	CcSEcCtD
Cevimeline—Dermatitis—Brimonidine—glaucoma	2.46e-05	0.00028	CcSEcCtD
Cevimeline—Dizziness—Travoprost—glaucoma	2.45e-05	0.00028	CcSEcCtD
Cevimeline—Malnutrition—Timolol—glaucoma	2.45e-05	0.00028	CcSEcCtD
Cevimeline—Oedema—Betaxolol—glaucoma	2.45e-05	0.000279	CcSEcCtD
Cevimeline—Headache—Brimonidine—glaucoma	2.44e-05	0.000279	CcSEcCtD
Cevimeline—Decreased appetite—Clonidine—glaucoma	2.44e-05	0.000279	CcSEcCtD
Cevimeline—Infection—Betaxolol—glaucoma	2.43e-05	0.000277	CcSEcCtD
Cevimeline—Fatigue—Clonidine—glaucoma	2.42e-05	0.000277	CcSEcCtD
Cevimeline—Dizziness—Brinzolamide—glaucoma	2.42e-05	0.000276	CcSEcCtD
Cevimeline—Nausea—Acetazolamide—glaucoma	2.41e-05	0.000276	CcSEcCtD
Cevimeline—Diarrhoea—Pilocarpine—glaucoma	2.41e-05	0.000275	CcSEcCtD
Cevimeline—Shock—Betaxolol—glaucoma	2.41e-05	0.000275	CcSEcCtD
Cevimeline—Constipation—Clonidine—glaucoma	2.4e-05	0.000274	CcSEcCtD
Cevimeline—Pain—Clonidine—glaucoma	2.4e-05	0.000274	CcSEcCtD
Cevimeline—Nervous system disorder—Betaxolol—glaucoma	2.4e-05	0.000274	CcSEcCtD
Cevimeline—Dysgeusia—Timolol—glaucoma	2.4e-05	0.000274	CcSEcCtD
Cevimeline—Thrombocytopenia—Betaxolol—glaucoma	2.39e-05	0.000273	CcSEcCtD
Cevimeline—Tachycardia—Betaxolol—glaucoma	2.39e-05	0.000273	CcSEcCtD
Cevimeline—Skin disorder—Betaxolol—glaucoma	2.38e-05	0.000271	CcSEcCtD
Cevimeline—Vomiting—Dorzolamide—glaucoma	2.37e-05	0.00027	CcSEcCtD
Cevimeline—Hyperhidrosis—Betaxolol—glaucoma	2.36e-05	0.00027	CcSEcCtD
Cevimeline—Rash—Dorzolamide—glaucoma	2.35e-05	0.000268	CcSEcCtD
Cevimeline—Dermatitis—Dorzolamide—glaucoma	2.35e-05	0.000268	CcSEcCtD
Cevimeline—Rash—Travoprost—glaucoma	2.34e-05	0.000267	CcSEcCtD
Cevimeline—Dermatitis—Travoprost—glaucoma	2.34e-05	0.000267	CcSEcCtD
Cevimeline—Headache—Dorzolamide—glaucoma	2.33e-05	0.000266	CcSEcCtD
Cevimeline—Anorexia—Betaxolol—glaucoma	2.33e-05	0.000266	CcSEcCtD
Cevimeline—Vomiting—Brinzolamide—glaucoma	2.33e-05	0.000266	CcSEcCtD
Cevimeline—Dizziness—Pilocarpine—glaucoma	2.33e-05	0.000266	CcSEcCtD
Cevimeline—Headache—Travoprost—glaucoma	2.32e-05	0.000265	CcSEcCtD
Cevimeline—Nausea—Brimonidine—glaucoma	2.32e-05	0.000264	CcSEcCtD
Cevimeline—Feeling abnormal—Clonidine—glaucoma	2.31e-05	0.000264	CcSEcCtD
Cevimeline—Rash—Brinzolamide—glaucoma	2.31e-05	0.000264	CcSEcCtD
Cevimeline—Dermatitis—Brinzolamide—glaucoma	2.31e-05	0.000263	CcSEcCtD
Cevimeline—Gastrointestinal pain—Clonidine—glaucoma	2.3e-05	0.000262	CcSEcCtD
Cevimeline—Headache—Brinzolamide—glaucoma	2.29e-05	0.000262	CcSEcCtD
Cevimeline—Hypotension—Betaxolol—glaucoma	2.29e-05	0.000261	CcSEcCtD
Cevimeline—Vomiting—Pilocarpine—glaucoma	2.24e-05	0.000255	CcSEcCtD
Cevimeline—Urticaria—Clonidine—glaucoma	2.23e-05	0.000255	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Betaxolol—glaucoma	2.23e-05	0.000254	CcSEcCtD
Cevimeline—Abdominal pain—Clonidine—glaucoma	2.22e-05	0.000254	CcSEcCtD
Cevimeline—Body temperature increased—Clonidine—glaucoma	2.22e-05	0.000254	CcSEcCtD
Cevimeline—Rash—Pilocarpine—glaucoma	2.22e-05	0.000253	CcSEcCtD
Cevimeline—Dermatitis—Pilocarpine—glaucoma	2.22e-05	0.000253	CcSEcCtD
Cevimeline—Insomnia—Betaxolol—glaucoma	2.21e-05	0.000253	CcSEcCtD
Cevimeline—Nausea—Dorzolamide—glaucoma	2.21e-05	0.000253	CcSEcCtD
Cevimeline—Headache—Pilocarpine—glaucoma	2.2e-05	0.000252	CcSEcCtD
Cevimeline—Nausea—Travoprost—glaucoma	2.2e-05	0.000251	CcSEcCtD
Cevimeline—Vertigo—Timolol—glaucoma	2.2e-05	0.000251	CcSEcCtD
Cevimeline—Paraesthesia—Betaxolol—glaucoma	2.2e-05	0.000251	CcSEcCtD
Cevimeline—Syncope—Timolol—glaucoma	2.2e-05	0.000251	CcSEcCtD
Cevimeline—Dyspnoea—Betaxolol—glaucoma	2.18e-05	0.000249	CcSEcCtD
Cevimeline—Nausea—Brinzolamide—glaucoma	2.17e-05	0.000248	CcSEcCtD
Cevimeline—Palpitations—Timolol—glaucoma	2.16e-05	0.000247	CcSEcCtD
Cevimeline—Dyspepsia—Betaxolol—glaucoma	2.15e-05	0.000246	CcSEcCtD
Cevimeline—Loss of consciousness—Timolol—glaucoma	2.15e-05	0.000246	CcSEcCtD
Cevimeline—Cough—Timolol—glaucoma	2.14e-05	0.000244	CcSEcCtD
Cevimeline—Decreased appetite—Betaxolol—glaucoma	2.13e-05	0.000243	CcSEcCtD
Cevimeline—Hypertension—Timolol—glaucoma	2.11e-05	0.000241	CcSEcCtD
Cevimeline—Fatigue—Betaxolol—glaucoma	2.11e-05	0.000241	CcSEcCtD
Cevimeline—Constipation—Betaxolol—glaucoma	2.09e-05	0.000239	CcSEcCtD
Cevimeline—Pain—Betaxolol—glaucoma	2.09e-05	0.000239	CcSEcCtD
Cevimeline—Nausea—Pilocarpine—glaucoma	2.09e-05	0.000239	CcSEcCtD
Cevimeline—Myalgia—Timolol—glaucoma	2.08e-05	0.000238	CcSEcCtD
Cevimeline—Chest pain—Timolol—glaucoma	2.08e-05	0.000238	CcSEcCtD
Cevimeline—Arthralgia—Timolol—glaucoma	2.08e-05	0.000238	CcSEcCtD
Cevimeline—Anxiety—Timolol—glaucoma	2.08e-05	0.000237	CcSEcCtD
Cevimeline—Hypersensitivity—Clonidine—glaucoma	2.07e-05	0.000236	CcSEcCtD
Cevimeline—Discomfort—Timolol—glaucoma	2.06e-05	0.000235	CcSEcCtD
Cevimeline—Asthenia—Clonidine—glaucoma	2.02e-05	0.00023	CcSEcCtD
Cevimeline—Feeling abnormal—Betaxolol—glaucoma	2.02e-05	0.00023	CcSEcCtD
Cevimeline—Confusional state—Timolol—glaucoma	2.01e-05	0.00023	CcSEcCtD
Cevimeline—Oedema—Timolol—glaucoma	2e-05	0.000228	CcSEcCtD
Cevimeline—Pruritus—Clonidine—glaucoma	1.99e-05	0.000227	CcSEcCtD
Cevimeline—Infection—Timolol—glaucoma	1.98e-05	0.000227	CcSEcCtD
Cevimeline—Shock—Timolol—glaucoma	1.97e-05	0.000224	CcSEcCtD
Cevimeline—Nervous system disorder—Timolol—glaucoma	1.96e-05	0.000224	CcSEcCtD
Cevimeline—Urticaria—Betaxolol—glaucoma	1.94e-05	0.000222	CcSEcCtD
Cevimeline—Skin disorder—Timolol—glaucoma	1.94e-05	0.000222	CcSEcCtD
Cevimeline—Body temperature increased—Betaxolol—glaucoma	1.93e-05	0.000221	CcSEcCtD
Cevimeline—Hyperhidrosis—Timolol—glaucoma	1.93e-05	0.000221	CcSEcCtD
Cevimeline—Diarrhoea—Clonidine—glaucoma	1.92e-05	0.00022	CcSEcCtD
Cevimeline—Anorexia—Timolol—glaucoma	1.9e-05	0.000218	CcSEcCtD
Cevimeline—Hypotension—Timolol—glaucoma	1.87e-05	0.000213	CcSEcCtD
Cevimeline—Dizziness—Clonidine—glaucoma	1.86e-05	0.000212	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Timolol—glaucoma	1.82e-05	0.000208	CcSEcCtD
Cevimeline—Insomnia—Timolol—glaucoma	1.81e-05	0.000206	CcSEcCtD
Cevimeline—Hypersensitivity—Betaxolol—glaucoma	1.8e-05	0.000206	CcSEcCtD
Cevimeline—Paraesthesia—Timolol—glaucoma	1.79e-05	0.000205	CcSEcCtD
Cevimeline—Vomiting—Clonidine—glaucoma	1.79e-05	0.000204	CcSEcCtD
Cevimeline—Dyspnoea—Timolol—glaucoma	1.78e-05	0.000203	CcSEcCtD
Cevimeline—Somnolence—Timolol—glaucoma	1.78e-05	0.000203	CcSEcCtD
Cevimeline—Rash—Clonidine—glaucoma	1.77e-05	0.000202	CcSEcCtD
Cevimeline—Dermatitis—Clonidine—glaucoma	1.77e-05	0.000202	CcSEcCtD
Cevimeline—Headache—Clonidine—glaucoma	1.76e-05	0.000201	CcSEcCtD
Cevimeline—Dyspepsia—Timolol—glaucoma	1.76e-05	0.000201	CcSEcCtD
Cevimeline—Asthenia—Betaxolol—glaucoma	1.75e-05	0.0002	CcSEcCtD
Cevimeline—Decreased appetite—Timolol—glaucoma	1.74e-05	0.000198	CcSEcCtD
Cevimeline—Pruritus—Betaxolol—glaucoma	1.73e-05	0.000198	CcSEcCtD
Cevimeline—Fatigue—Timolol—glaucoma	1.72e-05	0.000197	CcSEcCtD
Cevimeline—Pain—Timolol—glaucoma	1.71e-05	0.000195	CcSEcCtD
Cevimeline—Diarrhoea—Betaxolol—glaucoma	1.67e-05	0.000191	CcSEcCtD
Cevimeline—Nausea—Clonidine—glaucoma	1.67e-05	0.000191	CcSEcCtD
Cevimeline—Feeling abnormal—Timolol—glaucoma	1.65e-05	0.000188	CcSEcCtD
Cevimeline—Gastrointestinal pain—Timolol—glaucoma	1.63e-05	0.000187	CcSEcCtD
Cevimeline—Dizziness—Betaxolol—glaucoma	1.62e-05	0.000185	CcSEcCtD
Cevimeline—FMO1—Tamoxifen metabolism—CYP1B1—glaucoma	1.59e-05	0.108	CbGpPWpGaD
Cevimeline—Urticaria—Timolol—glaucoma	1.59e-05	0.000181	CcSEcCtD
Cevimeline—Body temperature increased—Timolol—glaucoma	1.58e-05	0.00018	CcSEcCtD
Cevimeline—Abdominal pain—Timolol—glaucoma	1.58e-05	0.00018	CcSEcCtD
Cevimeline—Vomiting—Betaxolol—glaucoma	1.56e-05	0.000178	CcSEcCtD
Cevimeline—Rash—Betaxolol—glaucoma	1.54e-05	0.000176	CcSEcCtD
Cevimeline—Dermatitis—Betaxolol—glaucoma	1.54e-05	0.000176	CcSEcCtD
Cevimeline—Headache—Betaxolol—glaucoma	1.53e-05	0.000175	CcSEcCtD
Cevimeline—Hypersensitivity—Timolol—glaucoma	1.47e-05	0.000168	CcSEcCtD
Cevimeline—Nausea—Betaxolol—glaucoma	1.45e-05	0.000166	CcSEcCtD
Cevimeline—Asthenia—Timolol—glaucoma	1.43e-05	0.000164	CcSEcCtD
Cevimeline—Pruritus—Timolol—glaucoma	1.41e-05	0.000161	CcSEcCtD
Cevimeline—Diarrhoea—Timolol—glaucoma	1.37e-05	0.000156	CcSEcCtD
Cevimeline—Dizziness—Timolol—glaucoma	1.32e-05	0.000151	CcSEcCtD
Cevimeline—Vomiting—Timolol—glaucoma	1.27e-05	0.000145	CcSEcCtD
Cevimeline—Rash—Timolol—glaucoma	1.26e-05	0.000144	CcSEcCtD
Cevimeline—Dermatitis—Timolol—glaucoma	1.26e-05	0.000144	CcSEcCtD
Cevimeline—Headache—Timolol—glaucoma	1.25e-05	0.000143	CcSEcCtD
Cevimeline—Nausea—Timolol—glaucoma	1.19e-05	0.000136	CcSEcCtD
Cevimeline—FMO1—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	5.56e-06	0.0378	CbGpPWpGaD
Cevimeline—CHRM1—Circadian rythm related genes—ATOH7—glaucoma	4.42e-06	0.03	CbGpPWpGaD
Cevimeline—FMO1—Biological oxidations—GSTT1—glaucoma	3.71e-06	0.0252	CbGpPWpGaD
Cevimeline—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—glaucoma	3.05e-06	0.0207	CbGpPWpGaD
Cevimeline—CHRM3—GPCRs, Other—PTGFR—glaucoma	2.98e-06	0.0202	CbGpPWpGaD
Cevimeline—CYP3A4—Aflatoxin B1 metabolism—GSTM1—glaucoma	2.98e-06	0.0202	CbGpPWpGaD
Cevimeline—FMO1—Biological oxidations—CYP1B1—glaucoma	2.96e-06	0.0201	CbGpPWpGaD
Cevimeline—FMO1—Metapathway biotransformation—CYP1B1—glaucoma	2.92e-06	0.0198	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—CA5A—glaucoma	2.6e-06	0.0177	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—NARFL—glaucoma	2.6e-06	0.0177	CbGpPWpGaD
Cevimeline—CYP2D6—Tamoxifen metabolism—CYP1B1—glaucoma	2.36e-06	0.0161	CbGpPWpGaD
Cevimeline—FMO1—Biological oxidations—GSTM1—glaucoma	2.36e-06	0.0161	CbGpPWpGaD
Cevimeline—FMO1—Metapathway biotransformation—GSTM1—glaucoma	2.33e-06	0.0158	CbGpPWpGaD
Cevimeline—CHRM1—G alpha (q) signalling events—OPN4—glaucoma	1.86e-06	0.0127	CbGpPWpGaD
Cevimeline—CHRM3—G alpha (q) signalling events—OPN4—glaucoma	1.86e-06	0.0126	CbGpPWpGaD
Cevimeline—CYP2D6—Melatonin metabolism and effects—CYP1B1—glaucoma	1.83e-06	0.0124	CbGpPWpGaD
Cevimeline—CHRM1—Circadian rythm related genes—OPN4—glaucoma	1.76e-06	0.012	CbGpPWpGaD
Cevimeline—CYP3A4—Estrogen metabolism—CYP1B1—glaucoma	1.75e-06	0.0119	CbGpPWpGaD
Cevimeline—CHRM1—G alpha (q) signalling events—PTGFR—glaucoma	1.68e-06	0.0114	CbGpPWpGaD
Cevimeline—CHRM3—G alpha (q) signalling events—PTGFR—glaucoma	1.67e-06	0.0114	CbGpPWpGaD
Cevimeline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—OPN4—glaucoma	1.67e-06	0.0113	CbGpPWpGaD
Cevimeline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—OPN4—glaucoma	1.66e-06	0.0113	CbGpPWpGaD
Cevimeline—CHRM1—Regulation of Actin Cytoskeleton—MYLK—glaucoma	1.66e-06	0.0113	CbGpPWpGaD
Cevimeline—CHRM3—Regulation of Actin Cytoskeleton—MYLK—glaucoma	1.66e-06	0.0113	CbGpPWpGaD
Cevimeline—CHRM1—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	1.58e-06	0.0107	CbGpPWpGaD
Cevimeline—CHRM3—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	1.57e-06	0.0107	CbGpPWpGaD
Cevimeline—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	1.55e-06	0.0105	CbGpPWpGaD
Cevimeline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—PTGFR—glaucoma	1.5e-06	0.0102	CbGpPWpGaD
Cevimeline—CHRM3—GPCRs, Other—SMO—glaucoma	1.5e-06	0.0102	CbGpPWpGaD
Cevimeline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—PTGFR—glaucoma	1.5e-06	0.0102	CbGpPWpGaD
Cevimeline—CYP2D6—Melatonin metabolism and effects—EDN1—glaucoma	1.48e-06	0.01	CbGpPWpGaD
Cevimeline—CHRM1—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	1.44e-06	0.00979	CbGpPWpGaD
Cevimeline—CHRM3—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	1.44e-06	0.00976	CbGpPWpGaD
Cevimeline—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	1.4e-06	0.0095	CbGpPWpGaD
Cevimeline—CHRM1—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	1.3e-06	0.00881	CbGpPWpGaD
Cevimeline—CHRM3—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	1.29e-06	0.00879	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—CA1—glaucoma	1.27e-06	0.00863	CbGpPWpGaD
Cevimeline—CHRM1—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	1.23e-06	0.00839	CbGpPWpGaD
Cevimeline—CHRM3—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	1.23e-06	0.00836	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—CTSA—glaucoma	1.23e-06	0.00835	CbGpPWpGaD
Cevimeline—CYP2D6—Melatonin metabolism and effects—APOE—glaucoma	1.2e-06	0.00816	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—CA2—glaucoma	1.16e-06	0.00789	CbGpPWpGaD
Cevimeline—CHRM1—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	1.11e-06	0.00755	CbGpPWpGaD
Cevimeline—CHRM3—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	1.11e-06	0.00753	CbGpPWpGaD
Cevimeline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	1.05e-06	0.00714	CbGpPWpGaD
Cevimeline—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	1.02e-06	0.00694	CbGpPWpGaD
Cevimeline—CYP2D6—Oxidation by Cytochrome P450—CYP1B1—glaucoma	1.01e-06	0.00685	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—OPN4—glaucoma	9.4e-07	0.00639	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—OPN4—glaucoma	9.37e-07	0.00637	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—PTGFR—glaucoma	8.47e-07	0.00575	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—PTGFR—glaucoma	8.44e-07	0.00573	CbGpPWpGaD
Cevimeline—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	8.28e-07	0.00562	CbGpPWpGaD
Cevimeline—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	8.26e-07	0.00561	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—TXN—glaucoma	8.18e-07	0.00556	CbGpPWpGaD
Cevimeline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	6.68e-07	0.00453	CbGpPWpGaD
Cevimeline—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	6.59e-07	0.00448	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—CA5A—glaucoma	6.47e-07	0.00439	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—NARFL—glaucoma	6.47e-07	0.00439	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—GSTT1—glaucoma	6.34e-07	0.00431	CbGpPWpGaD
Cevimeline—CHRM1—Circadian rythm related genes—NGFR—glaucoma	6.27e-07	0.00426	CbGpPWpGaD
Cevimeline—CHRM1—Circadian rythm related genes—NTRK1—glaucoma	5.96e-07	0.00405	CbGpPWpGaD
Cevimeline—CHRM1—G alpha (q) signalling events—EDN1—glaucoma	5.58e-07	0.00379	CbGpPWpGaD
Cevimeline—CHRM3—G alpha (q) signalling events—EDN1—glaucoma	5.56e-07	0.00378	CbGpPWpGaD
Cevimeline—CYP2D6—Biological oxidations—GSTT1—glaucoma	5.52e-07	0.00375	CbGpPWpGaD
Cevimeline—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	5.41e-07	0.00368	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—OPN4—glaucoma	5.31e-07	0.00361	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—OPN4—glaucoma	5.3e-07	0.0036	CbGpPWpGaD
Cevimeline—CHRM1—Regulation of Actin Cytoskeleton—FN1—glaucoma	5.13e-07	0.00349	CbGpPWpGaD
Cevimeline—CHRM3—Regulation of Actin Cytoskeleton—FN1—glaucoma	5.12e-07	0.00348	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—ABCA1—glaucoma	5.06e-07	0.00343	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—CYP1B1—glaucoma	5.06e-07	0.00343	CbGpPWpGaD
Cevimeline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	4.99e-07	0.00339	CbGpPWpGaD
Cevimeline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	4.97e-07	0.00338	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—OPN4—glaucoma	4.82e-07	0.00328	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—OPN4—glaucoma	4.81e-07	0.00327	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—PTGFR—glaucoma	4.78e-07	0.00325	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—PTGFR—glaucoma	4.77e-07	0.00324	CbGpPWpGaD
Cevimeline—CHRM1—Circadian rythm related genes—FAS—glaucoma	4.67e-07	0.00317	CbGpPWpGaD
Cevimeline—CYP2D6—Biological oxidations—CYP1B1—glaucoma	4.4e-07	0.00299	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—PTGFR—glaucoma	4.34e-07	0.00295	CbGpPWpGaD
Cevimeline—CYP2D6—Metapathway biotransformation—CYP1B1—glaucoma	4.34e-07	0.00295	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—PTGFR—glaucoma	4.33e-07	0.00294	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—SMO—glaucoma	4.27e-07	0.0029	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—SMO—glaucoma	4.25e-07	0.00289	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—LRP12—glaucoma	4.11e-07	0.00279	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—LRP12—glaucoma	4.1e-07	0.00278	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—GSTM1—glaucoma	4.04e-07	0.00275	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CA5A—glaucoma	3.87e-07	0.00263	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—NARFL—glaucoma	3.87e-07	0.00263	CbGpPWpGaD
Cevimeline—CHRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	3.7e-07	0.00251	CbGpPWpGaD
Cevimeline—CHRM3—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	3.68e-07	0.0025	CbGpPWpGaD
Cevimeline—CYP3A4—Biological oxidations—GSTT1—glaucoma	3.61e-07	0.00245	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—MTHFR—glaucoma	3.57e-07	0.00243	CbGpPWpGaD
Cevimeline—CYP2D6—Biological oxidations—GSTM1—glaucoma	3.52e-07	0.00239	CbGpPWpGaD
Cevimeline—CYP2D6—Metapathway biotransformation—GSTM1—glaucoma	3.47e-07	0.00236	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—APOE—glaucoma	3.33e-07	0.00226	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—CAV1—glaucoma	3.29e-07	0.00224	CbGpPWpGaD
Cevimeline—CHRM1—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	3.23e-07	0.00219	CbGpPWpGaD
Cevimeline—CHRM3—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	3.22e-07	0.00219	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—CA1—glaucoma	3.16e-07	0.00215	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—CTSA—glaucoma	3.06e-07	0.00208	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—CA2—glaucoma	2.89e-07	0.00196	CbGpPWpGaD
Cevimeline—CYP3A4—Biological oxidations—CYP1B1—glaucoma	2.87e-07	0.00195	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—OPN4—glaucoma	2.85e-07	0.00194	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—OPN4—glaucoma	2.84e-07	0.00193	CbGpPWpGaD
Cevimeline—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	2.84e-07	0.00193	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—EDN1—glaucoma	2.81e-07	0.00191	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—EDN1—glaucoma	2.81e-07	0.00191	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—HEYL—glaucoma	2.65e-07	0.0018	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—HEYL—glaucoma	2.64e-07	0.00179	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PTGFR—glaucoma	2.57e-07	0.00174	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PTGFR—glaucoma	2.56e-07	0.00174	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—NARFL—glaucoma	2.53e-07	0.00172	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CA5A—glaucoma	2.53e-07	0.00172	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—NOS3—glaucoma	2.49e-07	0.00169	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—C3—glaucoma	2.46e-07	0.00167	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—C3—glaucoma	2.45e-07	0.00166	CbGpPWpGaD
Cevimeline—CYP3A4—Biological oxidations—GSTM1—glaucoma	2.3e-07	0.00156	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—PTGS2—glaucoma	2.28e-07	0.00155	CbGpPWpGaD
Cevimeline—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	2.27e-07	0.00154	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—SMO—glaucoma	2.19e-07	0.00149	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—SMO—glaucoma	2.18e-07	0.00148	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—TXN—glaucoma	2.04e-07	0.00138	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—RPTOR—glaucoma	2.01e-07	0.00136	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—RPTOR—glaucoma	2e-07	0.00136	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—NCK2—glaucoma	1.94e-07	0.00132	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—NCK2—glaucoma	1.94e-07	0.00132	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CA1—glaucoma	1.89e-07	0.00128	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CTSA—glaucoma	1.83e-07	0.00124	CbGpPWpGaD
Cevimeline—CHRM1—Circadian rythm related genes—TP53—glaucoma	1.75e-07	0.00119	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CA2—glaucoma	1.73e-07	0.00117	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—HDAC9—glaucoma	1.65e-07	0.00112	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—HDAC9—glaucoma	1.65e-07	0.00112	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—EDN1—glaucoma	1.59e-07	0.00108	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—EDN1—glaucoma	1.59e-07	0.00108	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—GSTT1—glaucoma	1.58e-07	0.00107	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—EDN1—glaucoma	1.44e-07	0.000981	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—EDN1—glaucoma	1.44e-07	0.000978	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—C3—glaucoma	1.39e-07	0.000944	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—C3—glaucoma	1.38e-07	0.000941	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—SMO—glaucoma	1.29e-07	0.000879	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—SMO—glaucoma	1.29e-07	0.000876	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—C3—glaucoma	1.26e-07	0.000857	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—C3—glaucoma	1.26e-07	0.000854	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—ABCA1—glaucoma	1.26e-07	0.000854	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—CYP1B1—glaucoma	1.26e-07	0.000854	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CA1—glaucoma	1.23e-07	0.000839	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—TXN—glaucoma	1.22e-07	0.000827	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CTSA—glaucoma	1.2e-07	0.000812	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—NTRK2—glaucoma	1.18e-07	0.000804	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—NTRK2—glaucoma	1.18e-07	0.000801	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CA2—glaucoma	1.13e-07	0.000767	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—NGFR—glaucoma	1.02e-07	0.00069	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—NGFR—glaucoma	1.01e-07	0.000688	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—GSTM1—glaucoma	1.01e-07	0.000683	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—NTRK1—glaucoma	9.65e-08	0.000655	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—NTRK1—glaucoma	9.62e-08	0.000653	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—GSTT1—glaucoma	9.44e-08	0.000641	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CDKN2B—glaucoma	8.89e-08	0.000604	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—MTHFR—glaucoma	8.88e-08	0.000604	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CDKN2B—glaucoma	8.86e-08	0.000602	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—EDN1—glaucoma	8.53e-08	0.00058	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—EDN1—glaucoma	8.5e-08	0.000578	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—APOE—glaucoma	8.27e-08	0.000562	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—CAV1—glaucoma	8.2e-08	0.000557	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—TXN—glaucoma	7.96e-08	0.000541	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—NGF—glaucoma	7.84e-08	0.000533	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—NGF—glaucoma	7.82e-08	0.000531	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CYP1B1—glaucoma	7.52e-08	0.000511	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—ABCA1—glaucoma	7.52e-08	0.000511	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—C3—glaucoma	7.45e-08	0.000506	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—C3—glaucoma	7.43e-08	0.000505	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—APOE—glaucoma	6.94e-08	0.000471	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—APOE—glaucoma	6.92e-08	0.00047	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CAV1—glaucoma	6.87e-08	0.000467	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CAV1—glaucoma	6.85e-08	0.000466	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—FN1—glaucoma	6.54e-08	0.000445	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—FN1—glaucoma	6.52e-08	0.000443	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—BAD—glaucoma	6.47e-08	0.000439	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—BAD—glaucoma	6.45e-08	0.000438	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—NOS3—glaucoma	6.2e-08	0.000421	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GSTT1—glaucoma	6.17e-08	0.000419	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—GSTM1—glaucoma	6.01e-08	0.000408	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—PTGS2—glaucoma	5.67e-08	0.000385	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—MTHFR—glaucoma	5.31e-08	0.000361	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—NOS3—glaucoma	5.2e-08	0.000353	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—NOS3—glaucoma	5.18e-08	0.000352	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—APOE—glaucoma	4.95e-08	0.000336	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ABCA1—glaucoma	4.92e-08	0.000334	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CYP1B1—glaucoma	4.92e-08	0.000334	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CAV1—glaucoma	4.9e-08	0.000333	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CDKN1B—glaucoma	4.5e-08	0.000306	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CDKN1B—glaucoma	4.49e-08	0.000305	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—MMP9—glaucoma	4.17e-08	0.000283	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—MMP9—glaucoma	4.16e-08	0.000282	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GSTM1—glaucoma	3.93e-08	0.000267	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—VEGFA—glaucoma	3.74e-08	0.000254	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—VEGFA—glaucoma	3.73e-08	0.000254	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—NOS3—glaucoma	3.71e-08	0.000252	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—MTHFR—glaucoma	3.47e-08	0.000236	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PTGS2—glaucoma	3.39e-08	0.00023	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—APOE—glaucoma	3.23e-08	0.00022	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CAV1—glaucoma	3.2e-08	0.000218	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—TP53—glaucoma	2.83e-08	0.000192	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—TP53—glaucoma	2.82e-08	0.000192	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—NOS3—glaucoma	2.42e-08	0.000165	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PTGS2—glaucoma	2.22e-08	0.000151	CbGpPWpGaD
